Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administering adenosine A2A receptor antagonist to reduce or suppress side effects of parkinson's disease therapy

Administering adenosine A2A receptor antagonist to reduce or suppress side effects of parkinson's disease therapy

US Patent 7727993 · Granted Jun 1, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense nucleic acid for treating amyotrophy2020
Pharmaceutical composition containing KW-6002 and fluoxetine or paroxentine2016
Pharmaceutical composition containing KW-6002 and fluoxetine or paroxentine2016
Method of treating an anxiety disorder2013
Pharmaceutical composition2013
Pharmaceutical composition2013
Method of treating an anxiety disorder2012
Pharmaceutical composition2011
Pharmaceutical composition2011
Agents for treating migraine2010
Adenosine A2A receptor antagonists for treating restless legs syndrome or noctur2010
Adenosine A2A receptor antagonists for treating restless legs syndrome or noctur2010